PM

Pramodini Medicare Ltd

Q2 FY27Healthcare Services

Pramodini Medicare Q2 Results 2026 (FY27) statement: Revenue & Margins

Q2 FY27 results statement: what the company reported on revenue, margins and capex.

Based on Pramodini Medicare Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.

Price₹105
Market cap₹232 Cr
P/E13.4

The short version

Revenue from operations for the half year ended September 30, 2026: Rs. 37.11 crore (Rs. 3,711.31 lakh). EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization):.

From Pramodini Medicare Ltd's Q2 FY27 earnings-call transcript · updated 14 Nov 2026.

How did Pramodini Medicare's revenue grow in the September 2026 quarter?

  • Revenue from operations for the half year ended September 30, 2026: Rs. 37.11 crore (Rs. 3,711.31 lakh).
  • Revenue from operations for the half year ended September 30, 2025: Rs. 27.75 crore (Rs. 2,774.61 lakh).
  • Year-on-year revenue growth: Approximately 33.7% increase from 2025 to 2026 half year.

What happened to Pramodini Medicare's margins in Q2 FY27?

See what Pramodini Medicare Ltd said on profitability & margins — free account, 30 seconds.

What capex is Pramodini Medicare planning?

  • Funding of capital expenditure for purchase of medical equipment towards existing and proposed diagnostic centers: Proposed amount Rs. 45.15 Crore; utilized Rs. 14.61 Crore till September 30, 2026; balance Rs. 30.54 Crore remaining.
  • IPO net proceeds from fresh issue Rs. 56.03 Crore; out of which Rs. 20.00 Crore utilized by September 30, 2026; Rs. 36.03 Crore balance to be utilized mainly for capex and general corporate purposes.
  • General corporate purposes and unidentified inorganic acquisition: Rs. 10.76 Crore proposed; Rs. 5.39 Crore utilized; Rs. 5.36 Crore balance.

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Pramodini Medicare raising money or cutting debt?

See what Pramodini Medicare Ltd said on fundraising & capital structure — free account, 30 seconds.

How big is Pramodini Medicare's order book?

See what Pramodini Medicare Ltd said on order book & pipeline — free account, 30 seconds.

More Q2 FY27 results in Healthcare Services

All Q2 FY27 results | Healthcare Services rankings

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Pramodini Medicare Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Pramodini Medicare Ltd Q2 FY27 results?

Revenue from operations for the half year ended September 30, 2026: Rs. 37.11 crore (Rs. 3,711.31 lakh). EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization):.

What is Pramodini Medicare Ltd share price analysis?

Pramodini Medicare Ltd currently shows a neutral. The stock trades at a P/E of 13.4 with a market cap of ₹232 Cr. Investors should review the full earnings analysis for detailed insights.

Is Pramodini Medicare Ltd planning capital expenditure?

Funding of capital expenditure for purchase of medical equipment towards existing and proposed diagnostic centers: Proposed amount Rs. 45.15 Crore; utilized Rs. 14.61 Crore till September 30, 2026; ba.

Keep Pramodini Medicare Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.